Cortical Excitability & Role of rTMS in Nicotine Use Disorder

Status Not yet recruiting

Clinical Trial Summary

Cortical excitability and role of repetitive transcranial magnetic stimulation in nicotine use disorder. Estimation of cortical excitability in heavy smoker patients and determination of role of repetitive transcranial magnetic stimulation for reducing nicotine craving.

Clinical Trial Description

Nicotine is one of the main components of cigarettes and affects the central nervous system mainly via nicotinic acetylcholine receptors. It has further effects on neuromodulation by regulating the release of dopamine, serotonin, glutamate and adrenaline. In studies, it has been shown that nicotine improves attention and working memory in animals and humans, while nicotine withdrawal leads to reduced working and verbal memory capacity in otherwise healthy tobacco smokers. In schizophrenics and patients suffering from attention deficit hyperactivity disorder, nicotine improves cognitive performance. A likely basis of the nicotinic effects on cognitive functions is its effect on cortical excitability and activity. Here, neurophysiological studies mainly base on animal experiments and have shown in vitro that the nicotinic acetylcholine receptors elicit neuronal depolarisation by inducing transmembrane cationic inward currents (Calcium), thus being involved in induction and modulation of neuroplasticity and cortical excitability.

Repetitive transcranial magnetic stimulation: is a non-invasive brain stimulation technique that has shown positive results in the treatment of depression, schizophrenia, and more recently addiction. Repetitive transcranial magnetic stimulation uses alternating magnetic fields to induce electric currents in the cortical tissue. Low-frequency as one hertz repetitive transcranial magnetic stimulation is believed to inhibit neuronal firing in a localized area and is used to induce virtual brain lesions. High-frequency as more than three hertz repetitive transcranial magnetic stimulation is believed to be excitatory in nature and can result in neuronal depolarization under the stimulating coil. However, the effects of repetitive transcranial magnetic stimulation are not limited to the site of stimulation and can induce changes in distant interconnected sites of the brain, and consequently may influence subcortical regions. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03264755
Study type	Interventional
Source	Assiut University
Contact	Ahmed Abdel Bakay, Assistant prof
Phone	01096477803
Email	ahmedbaki2020@yahoo.com
Status	Not yet recruiting
Phase	N/A
Start date	May 4, 2020
Completion date	December 4, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04284813` - Families With Substance Use and Psychosis: A Pilot Study	N/A
Completed	`NCT02511704` - Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and Cigarette	Phase 1
Completed	`NCT04568395` - Acute Effects of TCIG vs ECIG in PLWH	N/A
Completed	`NCT03338933` - Neurobiology of Alcohol and Nicotine Co-Addiction
Completed	`NCT03634839` - Effects of E-cigarette Flavors on Youth TCORS 2.0	Phase 1
Recruiting	`NCT05515354` - Smoking Cessation and Menstrual Cycle Phase	Phase 4
Withdrawn	`NCT06259630` - Nicotine Virtual Reality Conditioned Place Preference	Phase 4
Recruiting	`NCT06170138` - Study to Assess PK, PD, Nicotine Extraction, Palatability, Subjective Effects of Nicotine Pouches - Daily Nicotine Users	N/A
Not yet recruiting	`NCT05932745` - Effects of Novel E-cigarette Constituents on Adults TCORS 3.0	N/A
Recruiting	`NCT05766254` - Identify the Optimal TMS Target to Modulate Reward Activity	N/A
Completed	`NCT00330187` - Combined Pharmaco/Behavior Therapy in Adolescent Smokers	Phase 2
Completed	`NCT03635333` - Effects of E-Cigarette Flavors on Adults TCORS 2.0	Phase 1
Completed	`NCT03438188` - Neural Basis of Eating Behavior in Abstinent Smokers	N/A
Completed	`NCT03194958` - Helping Poor Smokers Quit	N/A
Recruiting	`NCT04432064` - Temporal Interference Neurostimulation and Addiction	N/A
Recruiting	`NCT05181891` - Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking	Phase 2
Completed	`NCT05897242` - A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults	N/A
Not yet recruiting	`NCT05994209` - Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors	Phase 1
Completed	`NCT03302026` - Real Time fMRI and Quitting Smoking	N/A
Terminated	`NCT03352609` - Accelerated rTMS for the Reduction of Nicotine Craving	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Cortical Excitability and Role of rTMS in Nicotine Use Disorder

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms